Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats.
Naunyn Schmiedebergs Arch Pharmacol
; 392(8): 1005-1013, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31025143
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-6
/
Diabetes Mellitus, Experimental
/
Diabetic Nephropathies
/
Antibodies, Monoclonal, Humanized
/
Hypoglycemic Agents
Limits:
Animals
Language:
En
Journal:
Naunyn Schmiedebergs Arch Pharmacol
Year:
2019
Document type:
Article
Country of publication:
Germany